December 19, 2023 - Page 13 of 15

NASDAQ Companies - December 19, 2023

Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer’s Disease

NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

NASDAQ Companies - December 19, 2023

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), […]

NASDAQ Companies - December 19, 2023

Cardlytics Announces Multi-Year Contract Renewal with Lloyds Bank Plc

ATLANTA, Dec. 19, 2023 (GLOBE NEWSWIRE) — Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, announced that Cardlytics […]

NASDAQ Companies - December 19, 2023

Mama’s Creations, Inc. Announces Pricing of the Public Secondary Offering of Common Stock by Selling Stockholders

EAST RUTHERFORD, NJ, Dec. 19, 2023 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (Nasdaq: MAMA) (“Mama’s Creations” or the “Company”), a […]

NASDAQ Companies - December 19, 2023

Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, […]

NASDAQ Companies - December 19, 2023

uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to […]

NASDAQ Companies - December 19, 2023

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company […]

NASDAQ Companies - December 19, 2023

BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction

SUNNYVALE, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the […]

NASDAQ Companies - December 19, 2023

BioCryst Announces Publication of Data from Open-label Extension of the APeX-2 Pivotal Trial of ORLADEYO® (berotralstat)

RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that data from the […]

NASDAQ Companies - December 19, 2023

SweetWater Brewing Announces 27th Anniversary Party Concert Lineup

EarthGang to Headline and Light Up SweetWater Anniversary Musical showcase also includes Daniel Donato’s Cosmic Country and Maddy O’Neal ATLANTA, […]